You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 3
  • 2 Exploratory analysis of postprogression and patient-centered outcomes in ariel3: a phase 3, randomized, placebo-controlled study of rucaparib maintenance treatment in patients with recurrent ovarian carcinoma

Citation Tools

Article menu

Download PDFPDF

Plenary sessions
Plenary 1
IGCS19-0455
2 Exploratory analysis of postprogression and patient-centered outcomes in ariel3: a phase 3, randomized, placebo-controlled study of rucaparib maintenance treatment in patients with recurrent ovarian carcinoma
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Coleman R, Oza A, Lorusso D, et al
2 Exploratory analysis of postprogression and patient-centered outcomes in ariel3: a phase 3, randomized, placebo-controlled study of rucaparib maintenance treatment in patients with recurrent ovarian carcinoma
International Journal of Gynecologic Cancer 2019;29:A1-A2.